Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Iris Buchanan-Perry, MD, MSc, FAAP
Healthcare Provider Associate Professor
Morehouse School of Medicine
720 Westview Drive
Atlanta, Georgia, United States
Dr. Buchanan serves as a Clinical Instructor in patients with hemoglobinopathies. Dr Buchanan has been involved in clinical research and care of patients with Sickle Cell Disease locally and nationally. Experience in national clinical trials includes Props I, Pre-operative transfusion study and STOP. She has recently submitted a proposal for a national collaboration in the modulating effect of various opioids on the development of the acute chest syndrome in patients with sickle cell disease. Dr. Buchanan has been a member of the NIH Sickle Cell Disease advisory board and is presently a board member of the Sickle Cell Disease Association of America (SCDAA) and the Sickle Cell Foundation of Georgia. Recent training includes a master’s degree in epidemiology. Dr. Buchanan is the Co-Director of the Division of Pediatric Research as well as Director of Research for the MSM pediatric residents, which involves in the training of research principles and study design.
+myBinderRelated Content
-
Impact of emergency department care on outcomes of acute pain events in children with sickle cell diseaseThe impact of emergency department (ED) ...
-
William Owen, MDDr. William Owen is a pediatric hematolo...
-
Sickle cell disease in the emergency departmentAcute painful episodes are the most comm...
-
SCDAA Teams with MedicAlert Foundation to Improve Emergency Outcomes During Sickle Cell Crises[Hanover, Md., June 26, 2023] – The Si...
-
Brigham and Women’s Sickle Cell Disease ClinicEach person with sickle cell disease is ...
-
Alecia Nero, MDA hematology specialist at UT Southweste...
-
Prodigy’s death shines light on slow progress against sickle cell diseaseThe death of the rap artist Prodigy (Alb...
